Home LiteratureArticle Details
PMID: 19034270 Published · ppublish English Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.

Molecular systems biology ·Vol. 4 ·2008-00-00 ·Pages 229

Brosh R, Shalgi R, Liran A, Landan G, Korotayev K, Nguyen GH, Enerly E, Johnsen H, Buganim Y, Solomon H, Goldstein I, Madar S, Goldfinger N, Børresen-Dale AL, Ginsberg D, Harris CC, Pilpel Y, Oren M, Rotter V

Abstract

Normal cell growth is governed by a complicated biological system, featuring multiple levels of control, often deregulated in cancers. The role of microRNAs (miRNAs) in the control of gene expression is now increasingly appreciated, yet their involvement in controlling cell proliferation is still not well understood. Here we investigated the mammalian cell proliferation control network consisting of transcriptional regulators, E2F and p53, their targets and a family of 15 miRNAs. Indicative of their significance, expression of these miRNAs is downregulated in senescent cells and in breast cancers harboring wild-type p53. These miRNAs are repressed by p53 in an E2F1-mediated manner. Furthermore, we show that these miRNAs silence antiproliferative genes, which themselves are E2F1 targets. Thus, miRNAs and transcriptional regulators appear to cooperate in the framework of a multi-gene transcriptional and post-transcriptional feed-forward loop. Finally, we show that, similarly to p53 inactivation, overexpression of representative miRNAs promotes proliferation and delays senescence, manifesting the detrimental phenotypic consequence of perturbations in this circuit. Taken together, these findings position miRNAs as novel key players in the mammalian cellular proliferation network.

MeSH Terms
Animals Breast Neoplasms Cell Proliferation Cellular Senescence E2F Transcription Factors/physiology E2F1 Transcription Factor Female Gene Expression Regulation, Neoplastic Gene Regulatory Networks/physiology Humans Male MicroRNAs/physiology Systems Biology Tumor Suppressor Protein p53/physiology
Chemicals
E2F Transcription Factors E2F1 Transcription Factor MicroRNAs Tumor Suppressor Protein p53
Authors & Affiliations
19 authors, click to expand affiliations / ORCID
Brosh Ran
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Shalgi Reut
Liran Atar
Landan Gilad
Korotayev Katya
Nguyen Giang Huong
Enerly Espen
Johnsen Hilde
Buganim Yosef
Solomon Hilla
Goldstein Ido
Madar Shalom
Goldfinger Naomi
Børresen-Dale Anne-Lise
Ginsberg Doron
Harris Curtis C
Pilpel Yitzhak
Oren Moshe
Rotter Varda
References (66)
66 references, click to expand
  1. miR-15 and miR-16 induce apoptosis by targeting BCL2.
    Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9 PMID: 16166262
  2. ATM is a target for positive regulation by E2F-1.
    Oncogene. 2003 Jan 16;22(2):161-7 PMID: 12527885
  3. A microRNA polycistron as a potential human oncogene.
    Nature. 2005 Jun 9;435(7043):828-33 PMID: 15944707
  4. Transcription factor and microRNA motif discovery: the Amadeus platform and a compendium of metazoan target sets.
    Genome Res. 2008 Jul;18(7):1180-9 PMID: 18411406
  5. Wild-type p53 can down-modulate the activity of various promoters.
    Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9979-83 PMID: 1946467
  6. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.
    Dev Biol. 2007 Oct 15;310(2):442-53 PMID: 17765889
  7. Common markers of proliferation.
    Nat Rev Cancer. 2006 Feb;6(2):99-106 PMID: 16491069
  8. Combinatorial microRNA target predictions.
    Nat Genet. 2005 May;37(5):495-500 PMID: 15806104
  9. Transcriptional repression mediated by the p53 tumour suppressor.
    Cell Death Differ. 2003 Apr;10(4):404-8 PMID: 12719716
  10. Regulation and function of the p53 tumor suppressor protein.
    Curr Opin Cell Biol. 2001 Jun;13(3):332-7 PMID: 11343904
  11. Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
    Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3627-32 PMID: 15738415
  12. Micromanagement of the immune system by microRNAs.
    Nat Rev Immunol. 2008 Feb;8(2):120-30 PMID: 18204468
  13. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.
    Cell. 2006 Mar 24;124(6):1169-81 PMID: 16564011
  14. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
    Mol Cell Biol. 2006 Nov;26(21):8191-201 PMID: 16940181
  15. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2014-24 PMID: 16609010
  16. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors.
    J Biol Chem. 2007 Jan 26;282(4):2130-4 PMID: 17135268
  17. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.
    Mol Cell Biol. 2008 Apr;28(7):2167-74 PMID: 18212054
  18. Regulation of the germinal center response by microRNA-155.
    Science. 2007 Apr 27;316(5824):604-8 PMID: 17463289
  19. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.
    Cancer Cell. 2006 Mar;9(3):189-98 PMID: 16530703
  20. MCM7 amplification and overexpression are associated with prostate cancer progression.
    Oncogene. 2006 Feb 16;25(7):1090-8 PMID: 16247466
  21. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
    Science. 2004 Feb 6;303(5659):844-8 PMID: 14704432
  22. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression.
    Mol Cell Biol. 2007 Mar;27(6):2240-52 PMID: 17242205
  23. RAS is regulated by the let-7 microRNA family.
    Cell. 2005 Mar 11;120(5):635-47 PMID: 15766527
  24. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.
    Cancer Cell. 2008 Mar;13(3):272-86 PMID: 18328430
  25. Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer.
    Mol Oncol. 2007 Sep;1(2):160-71 PMID: 19383292
  26. p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
    Mutat Res. 1999 Jul 16;428(1-2):23-32 PMID: 10517975
  27. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.
    Cancer Res. 2008 May 1;68(9):3193-203 PMID: 18451145
  28. A microRNA expression signature of human solid tumors defines cancer gene targets.
    Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 PMID: 16461460
  29. Oncomirs - microRNAs with a role in cancer.
    Nat Rev Cancer. 2006 Apr;6(4):259-69 PMID: 16557279
  30. miRNA profiling of naïve, effector and memory CD8 T cells.
    PLoS One. 2007 Oct 10;2(10):e1020 PMID: 17925868
  31. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Mol Cell. 2007 Jun 8;26(5):745-52 PMID: 17540599
  32. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130.
    Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2889-94 PMID: 18287052
  33. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
    Mol Cell Biol. 1993 Dec;13(12):7267-77 PMID: 8246949
  34. Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation.
    Cancer Res. 2005 Jun 1;65(11):4530-43 PMID: 15930270
  35. DAVID: Database for Annotation, Visualization, and Integrated Discovery.
    Genome Biol. 2003;4(5):P3 PMID: 12734009
  36. Cellular senescence: when bad things happen to good cells.
    Nat Rev Mol Cell Biol. 2007 Sep;8(9):729-40 PMID: 17667954
  37. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts.
    Cancer Res. 2006 Nov 15;66(22):10671-6 PMID: 17108103
  38. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
    Cell Cycle. 2007 Jul 1;6(13):1586-93 PMID: 17554199
  39. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.
    Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15472-7 PMID: 17875987
  40. The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation.
    Mol Syst Biol. 2005;1:2005.0022 PMID: 16729057
  41. Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins.
    Oncogene. 1998 Dec 31;17(26):3463-9 PMID: 10030670
  42. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
    Genes Dev. 1994 Jul 1;8(13):1514-25 PMID: 7958836
  43. An E2F/miR-20a autoregulatory feedback loop.
    J Biol Chem. 2007 Jan 26;282(4):2135-43 PMID: 17135249
  44. Decision making by p53: life, death and cancer.
    Cell Death Differ. 2003 Apr;10(4):431-42 PMID: 12719720
  45. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Mol Cell. 2007 Jun 8;26(5):731-43 PMID: 17540598
  46. c-Myc-regulated microRNAs modulate E2F1 expression.
    Nature. 2005 Jun 9;435(7043):839-43 PMID: 15944709
  47. Identification of genes periodically expressed in the human cell cycle and their expression in tumors.
    Mol Biol Cell. 2002 Jun;13(6):1977-2000 PMID: 12058064
  48. Alterations in expression of E2F-1 and E2F-responsive genes by RB, p53 and p21(Sdi1/WAF1/Cip1) expression.
    FEBS Lett. 2001 Jun 29;500(1-2):25-30 PMID: 11434920
  49. ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry.
    Cell Signal. 2008 Jun;20(6):1221-6 PMID: 18396012
  50. Identifying regulatory networks by combinatorial analysis of promoter elements.
    Nat Genet. 2001 Oct;29(2):153-9 PMID: 11547334
  51. Mutant p53 proteins bind DNA abnormally in vitro.
    Oncogene. 1991 Jan;6(1):131-6 PMID: 1846954
  52. Global and local architecture of the mammalian microRNA-transcription factor regulatory network.
    PLoS Comput Biol. 2007 Jul;3(7):e131 PMID: 17630826
  53. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
    Cancer Res. 2003 Nov 1;63(21):7147-57 PMID: 14612508
  54. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
    JAMA. 2008 Jan 30;299(4):425-36 PMID: 18230780
  55. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    EMBO J. 2007 Sep 5;26(17):3968-80 PMID: 17690688
  56. Molecular evolution of a microRNA cluster.
    J Mol Biol. 2004 May 28;339(2):327-35 PMID: 15136036
  57. A microRNA component of the p53 tumour suppressor network.
    Nature. 2007 Jun 28;447(7148):1130-4 PMID: 17554337
  58. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.
    Mol Cell Biol. 1999 Sep;19(9):6379-95 PMID: 10454584
  59. Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution.
    Cell. 2005 Dec 16;123(6):1133-46 PMID: 16337999
  60. MicroRNAs: genomics, biogenesis, mechanism, and function.
    Cell. 2004 Jan 23;116(2):281-97 PMID: 14744438
  61. Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.
    Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10309-14 PMID: 8816796
  62. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.
    Nature. 2007 Feb 8;445(7128):656-60 PMID: 17251933
  63. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution.
    Science. 2005 Dec 16;310(5755):1817-21 PMID: 16308420
  64. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.
    Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9740-4 PMID: 15210942
  65. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    BMC Genomics. 2006 May 26;7:127 PMID: 16729877
  66. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Oncogene. 2007 May 24;26(24):3473-81 PMID: 17146434
Article Info
Journal
Molecular systems biology
Abbr.
Mol Syst Biol
ISSN
1744-4292
Published
2008-00-00
Epub
2008-00-25
Pages
229
Language
English
Region
England
NLM ID
101235389
PMCID
PMC2600669
Subset
IM
Grants
Intramural NIH HHS · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com